Browsing Tag
antibody therapy
2 posts
Can UPLIZNA transform gMG treatment? Amgen’s FDA win sets new benchmark for antibody-positive patients
Discover how Amgen’s UPLIZNA is redefining generalized myasthenia gravis treatment after FDA approval. Find out what this means for patients and investors.
Is Immuron (ASX: IMC) quietly staging a turnaround? PROIBS launch sparks 20% rally
Immuron (ASX: IMC) shares jumped 20 percent following its IBS product launch. Can the PROIBS rollout turn this microcap into a digestive health contender?